• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受持续肾脏替代治疗的重症患者净超滤强度的预后影响:多变量及倾向评分匹配分析

The prognostic impact of net ultrafiltration intensity in critically ill patients receiving continuous renal replacement therapy: a multivariable and propensity-matched analysis.

作者信息

Jin Lu, Li Peiyun, Tang Youli, Yin Wanhong, Wang Fang, Zhang Ling

机构信息

Division of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, China.

Department of Critical Care Medicine, Wenjiang District People's Hospital, Chengdu, China.

出版信息

Ren Fail. 2025 Dec;47(1):2537810. doi: 10.1080/0886022X.2025.2537810. Epub 2025 Jul 29.

DOI:10.1080/0886022X.2025.2537810
PMID:40731255
Abstract

OBJECTIVES

Net ultrafiltration (UF) is widely used for fluid management during continuous renal replacement therapy (CRRT) for critically ill patients over extended periods. Despite widespread use, the relationship between UF intensity and clinical outcomes, particularly mortality, remains controversial.

METHODS

This retrospective observational study examined critically ill patients undergoing CRRT for more than 72 h from January 2021 to September 2023. Patients were stratified by their UF intensity during the initial 72 h of CRRT into low (<1.01 mL/kg/h), moderate (1.01-1.75 mL/kg/h), and high (>1.75 mL/kg/h) groups. The primary outcome was 28-day mortality. Kaplan-Meier's survival curves with log-rank tests, Cox proportional hazards models, and propensity score matching were employed to assess the association between UF intensity and mortality.

RESULTS

A total of 683 patients were included. Compared with the moderate UF intensity, the low UF intensity (adjusted hazard ratio (HR) 1.54, 95%CI 1.24-1.91,  = .024) and high UF intensity (adjusted HR 1.27, 95%CI 1.03-1.57,  < .001) were associated with higher 28-day mortality. Sensitivity analyses showed similar trends for 60-day and 90-day mortality. Subgroup analyses based on admission diagnosis did not reveal significant differences in the effect of UF intensity on mortality risk.

CONCLUSIONS

UF intensity between 1.01 and 1.75 mL/kg/h during the first 72 h of CRRT was associated with lower 28-day mortality compared to both lower and higher UF intensities. However, future studies are needed to better define optimal UF thresholds in multicenter ICU cohorts.

摘要

目的

在危重症患者的持续肾脏替代治疗(CRRT)过程中,净超滤(UF)被广泛用于长期的液体管理。尽管使用广泛,但超滤强度与临床结局,尤其是死亡率之间的关系仍存在争议。

方法

这项回顾性观察性研究对2021年1月至2023年9月期间接受CRRT超过72小时的危重症患者进行了检查。根据CRRT初始72小时内的超滤强度,将患者分为低超滤强度组(<1.01 mL/kg/h)、中超滤强度组(1.01 - 1.75 mL/kg/h)和高超滤强度组(>1.75 mL/kg/h)。主要结局是28天死亡率。采用Kaplan-Meier生存曲线结合对数秩检验、Cox比例风险模型和倾向评分匹配来评估超滤强度与死亡率之间的关联。

结果

共纳入683例患者。与中超滤强度相比,低超滤强度(调整后风险比(HR)1.54,95%置信区间1.24 - 1.91,P = 0.024)和高超滤强度(调整后HR 1.27,95%置信区间1.03 - 1.57,P < 0.001)与28天死亡率较高相关。敏感性分析显示60天和90天死亡率有类似趋势。基于入院诊断的亚组分析未发现超滤强度对死亡风险的影响有显著差异。

结论

与较低和较高的超滤强度相比,CRRT前72小时内超滤强度在1.01至1.75 mL/kg/h之间与较低的28天死亡率相关。然而,未来需要进一步研究以更好地确定多中心重症监护病房队列中的最佳超滤阈值。

相似文献

1
The prognostic impact of net ultrafiltration intensity in critically ill patients receiving continuous renal replacement therapy: a multivariable and propensity-matched analysis.接受持续肾脏替代治疗的重症患者净超滤强度的预后影响:多变量及倾向评分匹配分析
Ren Fail. 2025 Dec;47(1):2537810. doi: 10.1080/0886022X.2025.2537810. Epub 2025 Jul 29.
2
Association of net ultrafiltration intensity and clinical outcomes among critically ill patients receiving continuous renal replacement therapy: A systematic review, meta-analysis, and trial sequential analysis.
Aust Crit Care. 2025 May;38(3):101170. doi: 10.1016/j.aucc.2024.101170. Epub 2025 Jan 30.
3
Reduction Rate of Uric Acid in Blood during Continuous Renal Replacement Therapy for Acute Kidney Injury: A Multicenter Retrospective Observational Study.急性肾损伤持续肾脏替代治疗期间血尿酸的降低率:一项多中心回顾性观察研究
Blood Purif. 2025;54(2):83-92. doi: 10.1159/000542329. Epub 2024 Oct 29.
4
Early Net Ultrafiltration during Continuous Renal Replacement Therapy: Impact of Admission Diagnosis and Association with Mortality.持续肾脏替代治疗期间的早期净超滤:入院诊断的影响及其与死亡率的关联
Blood Purif. 2024;53(3):170-180. doi: 10.1159/000535315. Epub 2023 Nov 22.
5
The role of a "volume sparing" strategy in kidney replacement therapy of AKI: a retrospective single-center study.“容量节约”策略在急性肾损伤肾脏替代治疗中的作用:一项回顾性单中心研究。
J Nephrol. 2025 Jan;38(1):235-241. doi: 10.1007/s40620-024-02142-z. Epub 2025 Jan 9.
6
Intensity of continuous renal replacement therapy for acute kidney injury.急性肾损伤的持续肾脏替代治疗强度
Cochrane Database Syst Rev. 2016 Oct 4;10(10):CD010613. doi: 10.1002/14651858.CD010613.pub2.
7
Determinants of Urine Output Using Advanced Hemodynamic Monitoring in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.使用先进的血流动力学监测在接受连续肾脏替代治疗的危重症患者中确定尿量的决定因素。
Blood Purif. 2024;53(3):189-199. doi: 10.1159/000535544. Epub 2023 Dec 16.
8
Net ultrafiltration intensity and mortality in critically ill patients with fluid overload.液体超负荷的危重症患者的净超滤强度与死亡率。
Crit Care. 2018 Sep 24;22(1):223. doi: 10.1186/s13054-018-2163-1.
9
Impact of dexamethasone therapy on mortality in critically ill patients with non-traumatic intracerebral hemorrhage: a propensity score-matched cohort study.地塞米松治疗对非创伤性脑出血重症患者死亡率的影响:一项倾向评分匹配队列研究。
Sci Rep. 2025 Jul 17;15(1):25993. doi: 10.1038/s41598-025-11735-y.
10
Early net ultrafiltration thresholds and mortality in critically ill patients with septic acute kidney injury receiving continuous renal replacement therapy.接受连续性肾脏替代治疗的脓毒症急性肾损伤重症患者的早期净超滤阈值与死亡率
Ren Fail. 2025 Dec;47(1):2511277. doi: 10.1080/0886022X.2025.2511277. Epub 2025 May 29.

本文引用的文献

1
Early Net Ultrafiltration during Continuous Renal Replacement Therapy: Impact of Admission Diagnosis and Association with Mortality.持续肾脏替代治疗期间的早期净超滤:入院诊断的影响及其与死亡率的关联
Blood Purif. 2024;53(3):170-180. doi: 10.1159/000535315. Epub 2023 Nov 22.
2
Fluid assessment, fluid balance, and fluid overload in sick children: a report from the Pediatric Acute Disease Quality Initiative (ADQI) conference.患病儿童的液体评估、液体平衡及液体超负荷:来自儿科急性疾病质量改进计划(ADQI)会议的报告
Pediatr Nephrol. 2024 Mar;39(3):955-979. doi: 10.1007/s00467-023-06156-w. Epub 2023 Nov 7.
3
Standardization of Nomenclature for the Mechanisms and Materials Utilized for Extracorporeal Blood Purification.
体外血液净化中所使用的机制和材料的命名标准化。
Blood Purif. 2024;53(5):329-342. doi: 10.1159/000533330. Epub 2023 Sep 13.
4
Fluid Overload and Precision Net Ultrafiltration in Critically Ill Patients.危重症患者液体超负荷与精准净超滤
Cardiorenal Med. 2023;13(1):9-18. doi: 10.1159/000527390. Epub 2022 Oct 6.
5
The Association of an Early Net Ultrafiltration Rate and 28-Day Mortality in Patients Receiving Continuous Kidney Replacement Therapy.接受连续性肾脏替代治疗患者的早期净超滤率与28天死亡率的相关性
Front Med (Lausanne). 2021 Dec 2;8:766557. doi: 10.3389/fmed.2021.766557. eCollection 2021.
6
Statistics From A (Agreement) to Z (z Score): A Guide to Interpreting Common Measures of Association, Agreement, Diagnostic Accuracy, Effect Size, Heterogeneity, and Reliability in Medical Research.从A(一致性)到Z(Z分数)的统计学:医学研究中关联、一致性、诊断准确性、效应量、异质性和可靠性常用指标解读指南。
Anesth Analg. 2021 Dec 1;133(6):1633-1641. doi: 10.1213/ANE.0000000000005773.
7
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.拯救脓毒症运动:2021年脓毒症和脓毒性休克国际管理指南
Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2.
8
Kidney Replacement Therapy for Fluid Management.用于液体管理的肾脏替代疗法。
Crit Care Clin. 2021 Apr;37(2):433-452. doi: 10.1016/j.ccc.2020.11.006. Epub 2021 Feb 13.
9
Net ultrafiltration rate and its impact on mortality in patients with acute kidney injury receiving continuous renal replacement therapy.接受连续性肾脏替代治疗的急性肾损伤患者的净超滤率及其对死亡率的影响。
Clin Kidney J. 2019 Dec 17;14(2):564-569. doi: 10.1093/ckj/sfz179. eCollection 2021 Feb.
10
Net ultrafiltration prescription survey in Europe.欧洲网络超滤处方调查。
BMC Nephrol. 2020 Dec 1;21(1):522. doi: 10.1186/s12882-020-02184-y.